Investment analysts at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the ...

While the big animals with their paddle-like antlers once roamed across Michigan, by the early 1900s, their numbers had grown ...